Assignee
NKMAX CO LTD
KR·6 granted patents·6 pending applications·12 citations·filing 2013–2024
Top patents by PatentIndex Score
12 records- 0187US10590385B2Method of producing natural killer cells and composition for treating cancerNKMAX CO LTD·Filed 2019·Granted Mar 17, 2020·4 cites·18 claims
- 0286US12379384B2Method of diagnosing cancer and diagnosis kit using measurement of NK cell activityNKMAX CO LTD·Filed 2022·Granted Aug 5, 2025·1 cites·17 claims
- 0386US11066644B2Method of producing natural killer cells and composition for treating cancerNKMAX CO LTD·Filed 2020·Granted Jul 20, 2021·2 cites·20 claims
- 0483US9938498B2Method for the induction and expansion of natural killer cells derived from peripheral blood mononuclear cellsNKMAX CO LTD·Filed 2013·Granted Apr 10, 2018·4 cites·5 claims
- 0580US2025059510A1Method of producing natural killer cells and composition for treating cancerNKMAX CO LTD·Filed 2024·Application pending·0 cites
- 0671US11504396B2Pharmaceutical composition and methods comprising immune cells and ponatinibNKMAX CO LTD·Filed 2017·Granted Nov 22, 2022·1 cites·25 claims
- 0769US12098388B2Method of producing natural killer cells and composition for treating cancerNKMAX CO LTD·Filed 2020·Granted Sep 24, 2024·0 cites·18 claims
- 0866US2025255903A1Method of treating parkinson's disease with expanded natural killer cellsNKMAX CO LTD·Filed 2023·Application pending·0 cites
- 0963US2025195574A1Method for reduction of immune checkpoint therapy related adverse eventsNKMAX CO LTD·Filed 2023·Application pending·0 cites
- 1062US2026048083A1Method of treating alzheimer's disease with expanded natural killer cellsNKMAX CO LTD·Filed 2023·Application pending·0 cites
- 1153US2023002731A1Method of producing natural killer cells and compositions thereofNKMAX CO LTD·Filed 2020·Application pending·0 cites
- 1252US2018223257A1Method for the induction and expansion of natural killer cells derived from peripheral blood mononuclear cellsNKMAX CO LTD·Filed 2018·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →